News for PsyBio Therapeutics Corp. (PSYB.V)

Experts gathered at the Benzinga Psychedelics Capital Conference in Miami Beach on Thursday where they talked about revolutionizing psychedelic therapy as a promising new approach for treating mental health conditions and how clinical dat

Oxford, Ohio and Denver, Colorado - April 6, 2023 (Newsfile Corp.) (Investorideas.com Newswire) PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" ...

Biotech company PsyBio Therapeutics Corp. (OTCQB: PSYBF) has filed four new U.S. Patent Cooperation Treaty (PCT) applications aiming to convert five provisional patent applications.

PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) reported its unaudited interim financial results for the three and nine-month period ended September 30, 2022.

The current clinical scenario sets psilocybin as one of the most advanced psychedelics, expected to become legally approved in the US sometime between the 2023-2024 period and to become available as of Januar

Vancouver, Kelowna, Delta, BC - May 13, 2022 (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces its w...

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.

Vancouver drug-research companies are seeking cheaper ways to produce psychedelic mushrooms, or the active ingredient psilocybin, to cater to new demand.

Burns & Levinson Expands National Cannabis Business Law Practice  Boston-based Burns & Levinson LLP annou...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

VANCOUVER, BC, June 22, 2021 /CNW/ - TSX VENTURE COMPANIESACADEMY METALS INC. ('AM')BULLETIN TYPE:  ConsolidationBULLETIN DATE:  June 22, 2021TSX ...